VDAC1 and type 2 diabetes mellitus: 29 VDAC1 was mistargeted to the plasma membrane, where it co-localized with soluble NSF-attachment receptor (SNARE) proteins, and has been suggested to impair GSIS in the setting of glucotoxicity and T2D.